Zenosense, Inc. (ZENO) Gaining Steam as Lung Cancer Detection Trial Ramps Up
Zenosense has been working with a large university hospital in Madrid, Spain to test the effectiveness of its specially designed volatile organic compound (VOC) detection techniques. The collaboration is particularly promising, because, in addition to its work with Zenosense, the university hospital has been directly involved in a number of published studies focusing on the detection of VOCs in order to better identify various respiratory pathologies. While the 400 subject trial will serve as an excellent proof of concept, Zenosense hopes to considerably increase the size of its tests following positive initial results. The company expects the initial trial to…